0 Комментарии
0 Поделились
833 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Memantine market driven by demand for Alzheimer's disease drugs connected with market driver outline as a part of headingThe global Memantine Market is estimated to be valued at US$ 565.93 Bn in 2022 and is expected to exhibit a CAGR of 3.87% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Memantine is a prescription drug used for the treatment of moderate to severe Alzheimer's disease. It belongs to a class of drugs called NMDA receptor...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Memantine Market Poised for Growth Due to Advancements in Alzheimer's Disease TreatmentMemantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist primarily used for treating moderate to severe Alzheimer's disease. It functions by regulating glutamate activity and providing neuroprotection against toxicity. Memantine is approved as a treatment option either as a monotherapy or in combination with cholinesterase inhibitors for patients suffering from moderate to...0 Комментарии 0 Поделились 393 Просмотры 0 предпросмотр